| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Nucleus | 55 | 2020 | 2969 | 4.140 |
Why?
|
| RNA Splicing | 24 | 2011 | 907 | 2.120 |
Why?
|
| Cell Nucleus Structures | 7 | 2011 | 15 | 1.910 |
Why?
|
| Transcription, Genetic | 32 | 2013 | 7722 | 1.680 |
Why?
|
| Chromatin | 20 | 2015 | 2934 | 1.500 |
Why?
|
| RNA Precursors | 18 | 2009 | 208 | 1.460 |
Why?
|
| Gene Expression Regulation | 19 | 2022 | 12072 | 1.330 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2023 | 137 | 1.330 |
Why?
|
| Embryonic Stem Cells | 6 | 2022 | 1294 | 1.290 |
Why?
|
| Chromosomes | 9 | 2022 | 596 | 1.240 |
Why?
|
| Nuclear Proteins | 28 | 2013 | 5853 | 1.160 |
Why?
|
| RNA, Untranslated | 5 | 2010 | 453 | 1.070 |
Why?
|
| RNA-Binding Proteins | 13 | 2021 | 1903 | 0.870 |
Why?
|
| Mitosis | 8 | 2011 | 1208 | 0.810 |
Why?
|
| Cell Nucleolus | 6 | 2004 | 166 | 0.800 |
Why?
|
| RNA, Small Nuclear | 7 | 2010 | 65 | 0.780 |
Why?
|
| RNA Polymerase II | 9 | 2011 | 551 | 0.760 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2022 | 987 | 0.750 |
Why?
|
| RNA Processing, Post-Transcriptional | 7 | 2009 | 436 | 0.740 |
Why?
|
| Interphase | 7 | 2011 | 226 | 0.740 |
Why?
|
| Intranuclear Inclusion Bodies | 2 | 2010 | 37 | 0.710 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2023 | 8428 | 0.710 |
Why?
|
| Arabidopsis | 4 | 2007 | 459 | 0.670 |
Why?
|
| RNA, Messenger | 18 | 2021 | 13033 | 0.630 |
Why?
|
| Histones | 9 | 2012 | 2599 | 0.620 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2016 | 15 | 0.590 |
Why?
|
| HeLa Cells | 24 | 2010 | 3128 | 0.580 |
Why?
|
| Gastric Bypass | 4 | 2023 | 812 | 0.580 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2015 | 223 | 0.580 |
Why?
|
| Eukaryotic Cells | 4 | 2007 | 198 | 0.570 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 10 | 2010 | 72 | 0.550 |
Why?
|
| Cell Differentiation | 9 | 2022 | 11483 | 0.540 |
Why?
|
| Ribonucleoproteins | 9 | 1994 | 381 | 0.540 |
Why?
|
| Arabidopsis Proteins | 3 | 2007 | 262 | 0.520 |
Why?
|
| Gene Expression | 7 | 2022 | 7799 | 0.520 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 3647 | 0.510 |
Why?
|
| Luminescent Proteins | 10 | 2010 | 853 | 0.500 |
Why?
|
| Cell Line, Tumor | 14 | 2023 | 16689 | 0.500 |
Why?
|
| Hyperamylasemia | 1 | 2014 | 6 | 0.500 |
Why?
|
| Transcriptional Activation | 5 | 2013 | 1783 | 0.490 |
Why?
|
| Cell Cycle Proteins | 7 | 2013 | 3462 | 0.480 |
Why?
|
| Animals | 62 | 2024 | 168757 | 0.480 |
Why?
|
| RNA, Neoplasm | 1 | 2016 | 769 | 0.460 |
Why?
|
| Centromere | 4 | 2005 | 220 | 0.460 |
Why?
|
| Chromosomal Proteins, Non-Histone | 6 | 2013 | 736 | 0.460 |
Why?
|
| Response Elements | 1 | 2015 | 312 | 0.460 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2015 | 2649 | 0.450 |
Why?
|
| Alleles | 4 | 2022 | 6933 | 0.440 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2012 | 32 | 0.430 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 20822 | 0.430 |
Why?
|
| Nuclear Lamina | 2 | 2012 | 46 | 0.420 |
Why?
|
| Growth and Development | 1 | 2012 | 52 | 0.420 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2010 | 433 | 0.420 |
Why?
|
| Mice | 29 | 2024 | 81183 | 0.420 |
Why?
|
| Bariatric Surgery | 3 | 2023 | 952 | 0.410 |
Why?
|
| Lamin Type A | 1 | 2013 | 190 | 0.410 |
Why?
|
| Cytoplasm | 4 | 2008 | 1539 | 0.390 |
Why?
|
| Sequence Deletion | 1 | 2015 | 1526 | 0.390 |
Why?
|
| Poly A | 2 | 2005 | 185 | 0.390 |
Why?
|
| Dioxanes | 1 | 2010 | 37 | 0.380 |
Why?
|
| Cell Line | 18 | 2023 | 15997 | 0.380 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2010 | 43 | 0.380 |
Why?
|
| Leukemia, Promyelocytic, Acute | 3 | 2008 | 236 | 0.370 |
Why?
|
| Intestinal Obstruction | 1 | 2014 | 424 | 0.370 |
Why?
|
| Schizosaccharomyces | 4 | 2005 | 237 | 0.370 |
Why?
|
| Hemostasis, Surgical | 1 | 2010 | 128 | 0.360 |
Why?
|
| Lysine | 3 | 2011 | 1007 | 0.360 |
Why?
|
| Surgical Stapling | 1 | 2010 | 97 | 0.360 |
Why?
|
| Splenic Diseases | 1 | 2010 | 94 | 0.350 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2011 | 182 | 0.350 |
Why?
|
| Obesity, Morbid | 4 | 2023 | 1213 | 0.350 |
Why?
|
| Thionucleotides | 2 | 2000 | 107 | 0.340 |
Why?
|
| Cell Compartmentation | 8 | 1998 | 402 | 0.340 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2010 | 215 | 0.340 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2015 | 1101 | 0.340 |
Why?
|
| Cell Cycle | 6 | 2011 | 2967 | 0.330 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2214 | 0.330 |
Why?
|
| Microscopy, Fluorescence | 10 | 2011 | 2699 | 0.330 |
Why?
|
| Genome, Human | 4 | 2017 | 4420 | 0.330 |
Why?
|
| Glioblastoma | 1 | 2023 | 3481 | 0.320 |
Why?
|
| RNA | 6 | 2011 | 2749 | 0.320 |
Why?
|
| Histone Demethylases | 1 | 2011 | 321 | 0.310 |
Why?
|
| Hemostatics | 1 | 2010 | 229 | 0.310 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 795 | 0.310 |
Why?
|
| Mammals | 3 | 2022 | 1143 | 0.310 |
Why?
|
| Intestine, Small | 1 | 2014 | 1241 | 0.310 |
Why?
|
| Genome | 3 | 2012 | 1808 | 0.310 |
Why?
|
| Genetic Loci | 1 | 2017 | 2575 | 0.300 |
Why?
|
| Gene Silencing | 6 | 2005 | 1538 | 0.300 |
Why?
|
| Cytoplasmic Structures | 1 | 2006 | 21 | 0.290 |
Why?
|
| Cell Movement | 4 | 2020 | 5217 | 0.290 |
Why?
|
| Transcription Factors | 12 | 2022 | 12208 | 0.290 |
Why?
|
| Heterochromatin | 5 | 2013 | 296 | 0.290 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2005 | 201 | 0.290 |
Why?
|
| DNA-Binding Proteins | 12 | 2020 | 9648 | 0.290 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 413 | 0.290 |
Why?
|
| Green Fluorescent Proteins | 9 | 2008 | 2088 | 0.290 |
Why?
|
| Base Sequence | 12 | 2017 | 12797 | 0.290 |
Why?
|
| Organoids | 2 | 2023 | 701 | 0.280 |
Why?
|
| Blood Loss, Surgical | 1 | 2010 | 662 | 0.280 |
Why?
|
| Virus Assembly | 1 | 2006 | 144 | 0.270 |
Why?
|
| Antigens, Nuclear | 2 | 2008 | 192 | 0.270 |
Why?
|
| Microscopy, Electron | 10 | 2004 | 2645 | 0.260 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4253 | 0.260 |
Why?
|
| Telophase | 1 | 2004 | 7 | 0.260 |
Why?
|
| Ribonuclease III | 1 | 2007 | 275 | 0.260 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2004 | 158 | 0.240 |
Why?
|
| Humans | 81 | 2024 | 744343 | 0.240 |
Why?
|
| Disease Progression | 1 | 2020 | 13284 | 0.240 |
Why?
|
| Sequence Analysis, RNA | 3 | 2023 | 2012 | 0.240 |
Why?
|
| Fluorescent Antibody Technique | 11 | 2010 | 2505 | 0.230 |
Why?
|
| Adenoviridae | 2 | 2006 | 1099 | 0.230 |
Why?
|
| Computational Biology | 1 | 2015 | 3521 | 0.230 |
Why?
|
| Polymers | 1 | 2010 | 1621 | 0.220 |
Why?
|
| Laparoscopy | 3 | 2021 | 2151 | 0.220 |
Why?
|
| Phosphoproteins | 2 | 2004 | 2440 | 0.210 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 8863 | 0.210 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2013 | 3772 | 0.210 |
Why?
|
| Kinetics | 6 | 2011 | 6473 | 0.210 |
Why?
|
| Collagen | 1 | 2010 | 2689 | 0.200 |
Why?
|
| Cell Lineage | 3 | 2022 | 2504 | 0.200 |
Why?
|
| Cell Tracking | 2 | 2014 | 145 | 0.200 |
Why?
|
| Cricetinae | 8 | 2002 | 2472 | 0.200 |
Why?
|
| Genes, Reporter | 4 | 2010 | 1547 | 0.200 |
Why?
|
| Cytoplasmic Granules | 2 | 2002 | 610 | 0.200 |
Why?
|
| Cell-Matrix Junctions | 1 | 2020 | 23 | 0.200 |
Why?
|
| Microscopy, Video | 3 | 2014 | 245 | 0.190 |
Why?
|
| Protein Binding | 7 | 2020 | 9386 | 0.190 |
Why?
|
| Genomic Imprinting | 1 | 2022 | 328 | 0.190 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2001 | 211 | 0.190 |
Why?
|
| Cell Proliferation | 4 | 2021 | 10481 | 0.180 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2021 | 1990 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 1655 | 0.180 |
Why?
|
| Gastroplasty | 1 | 2021 | 142 | 0.180 |
Why?
|
| Mesoderm | 1 | 2022 | 686 | 0.170 |
Why?
|
| Subtraction Technique | 2 | 2014 | 525 | 0.170 |
Why?
|
| Homeodomain Proteins | 3 | 2015 | 2421 | 0.170 |
Why?
|
| Nuclear Envelope | 3 | 2001 | 172 | 0.170 |
Why?
|
| Cell Survival | 3 | 2020 | 5882 | 0.170 |
Why?
|
| Octamer Transcription Factors | 1 | 2018 | 23 | 0.160 |
Why?
|
| Introns | 3 | 1996 | 991 | 0.160 |
Why?
|
| Hemorrhage | 1 | 2010 | 3461 | 0.160 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 4851 | 0.160 |
Why?
|
| X Chromosome | 1 | 2001 | 814 | 0.160 |
Why?
|
| Fluorescence Recovery After Photobleaching | 2 | 2010 | 56 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 809 | 0.160 |
Why?
|
| Spermatocytes | 1 | 2017 | 42 | 0.150 |
Why?
|
| Lizards | 1 | 2017 | 55 | 0.150 |
Why?
|
| Organ Specificity | 2 | 2017 | 2008 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2013 | 1341 | 0.150 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 782 | 0.140 |
Why?
|
| DNA Replication | 3 | 2004 | 1399 | 0.140 |
Why?
|
| Molecular Sequence Data | 9 | 2008 | 18111 | 0.140 |
Why?
|
| Cells | 1 | 1997 | 168 | 0.140 |
Why?
|
| Protein Splicing | 1 | 2015 | 17 | 0.140 |
Why?
|
| Signal Transduction | 7 | 2022 | 23403 | 0.130 |
Why?
|
| Cell Line, Transformed | 3 | 1997 | 898 | 0.130 |
Why?
|
| Cell Communication | 1 | 2023 | 1621 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 1 | 2023 | 1376 | 0.130 |
Why?
|
| Chromosomes, Mammalian | 1 | 2015 | 151 | 0.130 |
Why?
|
| Hot Temperature | 3 | 1996 | 1354 | 0.130 |
Why?
|
| Serine | 1 | 1998 | 826 | 0.120 |
Why?
|
| Adenoviruses, Human | 2 | 1993 | 257 | 0.120 |
Why?
|
| Oligonucleotides | 1 | 2018 | 572 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13695 | 0.120 |
Why?
|
| Oligonucleotide Probes | 4 | 1996 | 427 | 0.120 |
Why?
|
| Acetylation | 2 | 2011 | 1085 | 0.120 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 351 | 0.120 |
Why?
|
| Neoplasm Proteins | 3 | 2002 | 3703 | 0.120 |
Why?
|
| Repressor Proteins | 3 | 2003 | 3023 | 0.120 |
Why?
|
| Amylases | 1 | 2014 | 173 | 0.120 |
Why?
|
| Targeted Gene Repair | 1 | 2013 | 20 | 0.120 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2002 | 1581 | 0.120 |
Why?
|
| Transfection | 4 | 2011 | 5892 | 0.120 |
Why?
|
| Breast | 1 | 2023 | 1969 | 0.120 |
Why?
|
| Oncogenes | 2 | 2018 | 1265 | 0.120 |
Why?
|
| Models, Biological | 7 | 2012 | 9583 | 0.120 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 913 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2001 | 4554 | 0.110 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2018 | 388 | 0.110 |
Why?
|
| Coiled Bodies | 2 | 2004 | 5 | 0.110 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2015 | 284 | 0.110 |
Why?
|
| Gastrectomy | 3 | 2023 | 663 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1997 | 581 | 0.110 |
Why?
|
| Cells, Cultured | 8 | 2014 | 19229 | 0.110 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 271 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 3616 | 0.110 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 13102 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2455 | 0.110 |
Why?
|
| Neoplasms | 3 | 2018 | 21683 | 0.110 |
Why?
|
| Deoxyribonucleases | 1 | 2013 | 214 | 0.100 |
Why?
|
| DNA, Satellite | 1 | 1992 | 69 | 0.100 |
Why?
|
| Lipase | 1 | 2014 | 314 | 0.100 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2010 | 285 | 0.100 |
Why?
|
| RNA, Double-Stranded | 1 | 1993 | 290 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2015 | 752 | 0.100 |
Why?
|
| Receptors, Transferrin | 1 | 2013 | 296 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2014 | 15295 | 0.100 |
Why?
|
| DNA Repair | 3 | 2008 | 2046 | 0.100 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 3505 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2003 | 2849 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 11366 | 0.100 |
Why?
|
| Biological Transport | 4 | 2004 | 2118 | 0.100 |
Why?
|
| Cyclin T | 1 | 2010 | 20 | 0.100 |
Why?
|
| Cellulose, Oxidized | 1 | 2010 | 12 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 2 | 2013 | 839 | 0.100 |
Why?
|
| Autoantigens | 2 | 2008 | 892 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2007 | 3752 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4751 | 0.090 |
Why?
|
| Sumoylation | 1 | 2011 | 83 | 0.090 |
Why?
|
| Metaphase | 2 | 2008 | 151 | 0.090 |
Why?
|
| Microscopy, Immunoelectron | 4 | 1996 | 319 | 0.090 |
Why?
|
| In Situ Hybridization | 4 | 1996 | 1950 | 0.090 |
Why?
|
| Microscopy | 2 | 2010 | 903 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2010 | 66 | 0.090 |
Why?
|
| Surgical Sponges | 1 | 2010 | 46 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2002 | 2899 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2016 | 1063 | 0.090 |
Why?
|
| Models, Structural | 1 | 1990 | 361 | 0.090 |
Why?
|
| Cullin Proteins | 1 | 2010 | 180 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 687 | 0.090 |
Why?
|
| Blastocyst | 1 | 2013 | 424 | 0.090 |
Why?
|
| DNA Damage | 2 | 2010 | 2432 | 0.090 |
Why?
|
| Tensile Strength | 1 | 2010 | 335 | 0.090 |
Why?
|
| Diffusion | 2 | 2003 | 833 | 0.090 |
Why?
|
| Phosphorylation | 5 | 2004 | 8436 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2021 | 2958 | 0.090 |
Why?
|
| Ribonuclease P | 1 | 2008 | 17 | 0.090 |
Why?
|
| Incretins | 1 | 2010 | 88 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1991 | 575 | 0.080 |
Why?
|
| Sus scrofa | 1 | 2010 | 437 | 0.080 |
Why?
|
| Acetylglucosamine | 1 | 2010 | 191 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2015 | 3144 | 0.080 |
Why?
|
| Multiprotein Complexes | 2 | 2013 | 1119 | 0.080 |
Why?
|
| Oncogene Proteins, Viral | 2 | 1988 | 362 | 0.080 |
Why?
|
| DNA Primers | 2 | 2005 | 2892 | 0.080 |
Why?
|
| Prophase | 1 | 2008 | 17 | 0.080 |
Why?
|
| Cyclin B1 | 1 | 2008 | 52 | 0.080 |
Why?
|
| Lamins | 1 | 2008 | 36 | 0.080 |
Why?
|
| Cyclin B | 1 | 2008 | 108 | 0.080 |
Why?
|
| Pattern Recognition, Automated | 2 | 2014 | 1005 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2015 | 2715 | 0.080 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 851 | 0.080 |
Why?
|
| RNA, Viral | 2 | 1993 | 2902 | 0.080 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2006 | 313 | 0.080 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2010 | 340 | 0.080 |
Why?
|
| Telomere | 2 | 2008 | 910 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 1504 | 0.070 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2011 | 635 | 0.070 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1941 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2014 | 1092 | 0.070 |
Why?
|
| Endoribonucleases | 1 | 2008 | 229 | 0.070 |
Why?
|
| Nuclear Matrix | 2 | 1998 | 28 | 0.070 |
Why?
|
| Materials Testing | 1 | 2010 | 867 | 0.070 |
Why?
|
| Spliceosomes | 2 | 2000 | 110 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2008 | 13815 | 0.070 |
Why?
|
| Macrophages | 1 | 2021 | 5655 | 0.070 |
Why?
|
| Cell Fractionation | 2 | 2005 | 252 | 0.070 |
Why?
|
| Histone Chaperones | 1 | 2006 | 76 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.070 |
Why?
|
| Cationic Amino Acid Transporter 2 | 1 | 2005 | 1 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 670 | 0.070 |
Why?
|
| Viral Core Proteins | 1 | 2006 | 162 | 0.070 |
Why?
|
| Female | 10 | 2023 | 380194 | 0.070 |
Why?
|
| CHO Cells | 3 | 1994 | 1406 | 0.070 |
Why?
|
| RNA, Transfer | 1 | 2008 | 316 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1992 | 1375 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2005 | 829 | 0.070 |
Why?
|
| Open Reading Frames | 1 | 2009 | 810 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 11725 | 0.070 |
Why?
|
| Plants, Genetically Modified | 1 | 2005 | 110 | 0.070 |
Why?
|
| Cycloheximide | 2 | 1996 | 347 | 0.070 |
Why?
|
| Nucleolus Organizer Region | 1 | 2004 | 26 | 0.060 |
Why?
|
| Euchromatin | 1 | 2004 | 56 | 0.060 |
Why?
|
| Chromosome Banding | 1 | 2004 | 278 | 0.060 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 2004 | 15 | 0.060 |
Why?
|
| Chromosome Structures | 1 | 2004 | 14 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9734 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9438 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 3617 | 0.060 |
Why?
|
| RNA Editing | 1 | 2005 | 148 | 0.060 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2004 | 112 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 677 | 0.060 |
Why?
|
| Plant Roots | 1 | 2004 | 109 | 0.060 |
Why?
|
| Mutagenesis | 2 | 1998 | 1266 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 513 | 0.060 |
Why?
|
| Plant Leaves | 1 | 2004 | 143 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2005 | 802 | 0.060 |
Why?
|
| Locus Control Region | 1 | 2003 | 20 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3597 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 6386 | 0.060 |
Why?
|
| Centrosome | 1 | 2004 | 201 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2008 | 3494 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1994 | 708 | 0.050 |
Why?
|
| Genomics | 2 | 2015 | 5720 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 19905 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 1081 | 0.050 |
Why?
|
| Chromosomes, Human | 1 | 2004 | 457 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 1736 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2014 | 4286 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2915 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2010 | 3846 | 0.050 |
Why?
|
| Male | 7 | 2022 | 350118 | 0.050 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2001 | 51 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2023 | 77449 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 3327 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 443 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 5867 | 0.050 |
Why?
|
| Fibroblasts | 3 | 2003 | 4161 | 0.050 |
Why?
|
| Obesity | 2 | 2016 | 12745 | 0.050 |
Why?
|
| Autoradiography | 2 | 1994 | 745 | 0.050 |
Why?
|
| Computer Systems | 1 | 2003 | 483 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 1861 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 2050 | 0.050 |
Why?
|
| Genotype | 1 | 2015 | 12951 | 0.050 |
Why?
|
| DNA | 3 | 2004 | 7301 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2001 | 323 | 0.050 |
Why?
|
| Lac Operon | 1 | 2000 | 238 | 0.050 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2001 | 298 | 0.050 |
Why?
|
| Time Factors | 5 | 2008 | 40075 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2004 | 5021 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 1009 | 0.050 |
Why?
|
| Swine | 1 | 2010 | 5917 | 0.050 |
Why?
|
| Myosins | 1 | 2002 | 409 | 0.050 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2001 | 191 | 0.050 |
Why?
|
| S Phase | 2 | 2010 | 423 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2006 | 2225 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1676 | 0.040 |
Why?
|
| Movement | 2 | 2008 | 1471 | 0.040 |
Why?
|
| Antigens | 2 | 1998 | 1466 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 704 | 0.040 |
Why?
|
| Learning Curve | 1 | 2021 | 208 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1990 | 2752 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1730 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 21827 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 2000 | 215 | 0.040 |
Why?
|
| Methylation | 1 | 2001 | 1106 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12959 | 0.040 |
Why?
|
| Scyphozoa | 1 | 1997 | 11 | 0.040 |
Why?
|
| Protein Transport | 1 | 2004 | 1988 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 203 | 0.040 |
Why?
|
| Cell Physiological Phenomena | 1 | 1999 | 154 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2005 | 2216 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2013 | 3523 | 0.040 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 1997 | 26 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 2001 | 749 | 0.040 |
Why?
|
| Globins | 2 | 1996 | 415 | 0.040 |
Why?
|
| Lung | 3 | 2024 | 9856 | 0.040 |
Why?
|
| Amanitins | 1 | 1996 | 4 | 0.040 |
Why?
|
| Clone Cells | 1 | 2000 | 1692 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14557 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2005 | 3206 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 4042 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 1213 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 2203 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 18029 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2002 | 1185 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 15519 | 0.030 |
Why?
|
| Templates, Genetic | 1 | 1996 | 211 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 6171 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2018 | 390 | 0.030 |
Why?
|
| Biotechnology | 1 | 1997 | 281 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 214055 | 0.030 |
Why?
|
| Age Factors | 1 | 2012 | 18370 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1996 | 573 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 1996 | 565 | 0.030 |
Why?
|
| Outpatients | 1 | 2022 | 1486 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1996 | 590 | 0.030 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2014 | 105 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1993 | 318 | 0.030 |
Why?
|
| DNA Cleavage | 1 | 2013 | 58 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 20129 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1993 | 70 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8664 | 0.030 |
Why?
|
| Microinjections | 1 | 1994 | 327 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2004 | 5974 | 0.030 |
Why?
|
| eIF-2 Kinase | 1 | 1993 | 149 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 1076 | 0.030 |
Why?
|
| Transferrin | 1 | 2013 | 295 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1114 | 0.030 |
Why?
|
| Yeasts | 1 | 1993 | 285 | 0.030 |
Why?
|
| DNA Probes | 1 | 1993 | 560 | 0.030 |
Why?
|
| Reoperation | 1 | 2021 | 4201 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 1992 | 322 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3586 | 0.030 |
Why?
|
| Image Enhancement | 2 | 2014 | 2921 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 1997 | 951 | 0.020 |
Why?
|
| Neutrophils | 1 | 2024 | 3719 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2023 | 63114 | 0.020 |
Why?
|
| Mutation | 4 | 2002 | 29786 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2013 | 585 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2001 | 2916 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2014 | 597 | 0.020 |
Why?
|
| Spheroplasts | 1 | 1990 | 6 | 0.020 |
Why?
|
| Proteomics | 1 | 2004 | 3638 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 6622 | 0.020 |
Why?
|
| Inpatients | 1 | 2022 | 2518 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3798 | 0.020 |
Why?
|
| Temperature | 1 | 1997 | 2206 | 0.020 |
Why?
|
| Gene Deletion | 1 | 1998 | 2751 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1991 | 549 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2010 | 210 | 0.020 |
Why?
|
| Guanosine | 1 | 1990 | 61 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 167 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 1991 | 1101 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2007 | 7880 | 0.020 |
Why?
|
| Drosophila | 1 | 1997 | 1491 | 0.020 |
Why?
|
| Thymidine | 1 | 1990 | 310 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2013 | 540 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1991 | 964 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 53288 | 0.020 |
Why?
|
| Tritium | 1 | 1990 | 745 | 0.020 |
Why?
|
| Uridine | 1 | 1990 | 146 | 0.020 |
Why?
|
| Algorithms | 3 | 2016 | 13881 | 0.020 |
Why?
|
| Adenoma, Islet Cell | 1 | 1988 | 82 | 0.020 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 1 | 2008 | 18 | 0.020 |
Why?
|
| Endocytosis | 1 | 2013 | 985 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2008 | 203 | 0.020 |
Why?
|
| Stem Cells | 1 | 2001 | 3567 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2002 | 3848 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2013 | 859 | 0.020 |
Why?
|
| Insulinoma | 1 | 1988 | 124 | 0.020 |
Why?
|
| Coturnix | 1 | 1987 | 21 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 14722 | 0.020 |
Why?
|
| Motion | 1 | 2010 | 798 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1992 | 6314 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 3282 | 0.020 |
Why?
|
| RNA Interference | 2 | 2005 | 2889 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2010 | 1060 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2010 | 852 | 0.020 |
Why?
|
| Antibodies | 2 | 1991 | 2460 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 2541 | 0.020 |
Why?
|
| Origin Recognition Complex | 1 | 2004 | 19 | 0.020 |
Why?
|
| Genes | 1 | 1988 | 1893 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1988 | 822 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3701 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1991 | 1640 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 1338 | 0.010 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2008 | 594 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21746 | 0.010 |
Why?
|
| Skin | 1 | 1997 | 4364 | 0.010 |
Why?
|
| Rats | 2 | 1992 | 24260 | 0.010 |
Why?
|
| Intracellular Space | 1 | 2004 | 212 | 0.010 |
Why?
|
| Genes, p16 | 1 | 2003 | 157 | 0.010 |
Why?
|
| Chromosome Segregation | 1 | 2004 | 235 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2003 | 277 | 0.010 |
Why?
|
| Kinetochores | 1 | 2004 | 194 | 0.010 |
Why?
|
| Simian virus 40 | 2 | 1996 | 295 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8388 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 1988 | 1352 | 0.010 |
Why?
|
| CpG Islands | 1 | 2005 | 1172 | 0.010 |
Why?
|
| Proteins | 1 | 1996 | 6103 | 0.010 |
Why?
|
| Cell Size | 1 | 2003 | 643 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2003 | 880 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 16365 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1997 | 6364 | 0.010 |
Why?
|
| Chromogranins | 1 | 1999 | 160 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 4320 | 0.010 |
Why?
|
| Vero Cells | 1 | 1999 | 485 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2010 | 2214 | 0.010 |
Why?
|
| Biology | 1 | 1999 | 294 | 0.010 |
Why?
|
| Computer Simulation | 2 | 2000 | 6196 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 6114 | 0.010 |
Why?
|
| Insulin | 1 | 1988 | 6580 | 0.010 |
Why?
|
| Casein Kinases | 1 | 1991 | 5 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1997 | 1117 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1988 | 5256 | 0.010 |
Why?
|
| Hydroxyurea | 1 | 1991 | 290 | 0.010 |
Why?
|
| Organelles | 1 | 1991 | 264 | 0.010 |
Why?
|
| Adenovirus Early Proteins | 1 | 1988 | 57 | 0.010 |
Why?
|
| Cell Division | 1 | 1996 | 4568 | 0.010 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1988 | 154 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 9727 | 0.000 |
Why?
|
| Cattle | 1 | 1991 | 3922 | 0.000 |
Why?
|
| Peptides | 1 | 1991 | 4409 | 0.000 |
Why?
|
| Liver | 1 | 1991 | 7474 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1988 | 9274 | 0.000 |
Why?
|
| Brain | 1 | 1991 | 26385 | 0.000 |
Why?
|